Cross-fund · 3 holders
ELDN
ELEDON PHARMACEUTICALS INC
CUSIP 28617K101
3
Tracked holders
$19.7M
Aggregate value
8,466,931
Shares
4
Active funds
Funds holding ELDN
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $13.5M | — | +755,037 | +20.8% |
| Vanguard | Institutional | Q4 2025 | $6.1M | — | +771,903 | +23.6% |
| Citadel | Multi-Strategy | Q1 2026 | $138,600 | — | -35,100 | -43.8% |
| Millennium | Multi-Strategy | Q1 2026 | — | — | -23,788 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.